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A behavioral intervention in a 
cohort of Japanese-Brazilians at 
high cardiometabolic risk
Intervenção comportamental em 
nipo-brasileiros com alto risco 
cardiometabólico
ABSTRACT
OBJECTIVE: To assess the effect of a health promotion program on 
cardiometabolic risk profi le in Japanese-Brazilians.
METHODS: A total of 466 subjects from a study on diabetes prevalence 
conducted in the city of Bauru, southeastern Brazil, in 2000 completed a 
1-year intervention program (2005-2006) based on healthy diet counseling and 
physical activity. Changes in blood pressure and metabolic parameters in the 
2005-2006 period were compared with annual changes in these same variables 
in the 2000-2005 period.
RESULTS: During the intervention, there were greater annual reductions in mean 
(SD) waist circumference [-0.5(3.8) vs. 1.2(1.2) cm per year, p<0.001], systolic 
blood pressure [-4.6(17.9) vs. 1.8(4.3) mmHg per year, p<0.001], 2-hour plasma 
glucose [-1.2(2.1) vs. –0.2(0.6) mmol/L per year, p<0.001], LDL-cholesterol 
[-0.3(0.9) vs. -0.1(0.2) mmol/L per year, p<0.001] and Framingham coronary 
heart disease risk score [-0.25(3.03) vs. 0.11(0.66) per year, p=0.02] but not 
in triglycerides [0.2(1.6) vs. 0.1(0.42) mmol/L per year, p<0.001], and fasting 
insulin level [1.2(5.8) vs. -0.7(2.2) IU/mL per year, p<0.001] compared with 
the pre-intervention period. Signifi cant reductions in the prevalence of impaired 
fasting glucose/impaired glucose tolerance and diabetes were seen during the 
intervention (from 58.4% to 35.4%, p<0.001; and from 30.1% to 21.7%, p= 
0.004, respectively).
CONCLUSIONS: A one-year community-based health promotion program 
brings cardiometabolic benefi ts in a high-risk population of Japanese-Brazilians.
DESCRIPTORS: Cardiovascular Diseases, prevention & control. 
Diabetes Mellitus, Type 2, prevention & control. Evaluation of the 
Effi cacy-Effectiveness of Interventions. Food and Nutrition Education. 
Physical Education and Training. Asian Continental Ancestry Group.
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Several trials have confi rmed that type 2 diabetes is 
preventable through intensive lifestyle interventions 
focusing on diet and physical activity among those with 
impaired glucose tolerance.8,21 Although the reduction 
in the incidence of diabetes assessed by annual glucose 
tolerance test was around 58%, the magnitude of 
changes in cardiovascular risk factors was more modest. 
Furthermore, glucose tolerance tests are unlikely to be 
a practical strategy to identify high-risk individuals and 
intensive lifestyle interventions such as those proposed 
in diabetes prevention trials are not widely available. 
The challenge is therefore to translate the fi ndings 
of diabetes prevention trials into strategies to reduce 
cardiometabolic risk in the general population.19
One of the highest prevalence rates of diabetes worl-
dwide have been reported in Japanese-Brazilians5 
who also have many other cardiovascular risk 
factors.16 Cardiovascular disease was seen in 14% 
of this population20 in 2000. Unhealthy diet and low 
physical activity have been the culprit risk factors for 
RESUMO
OBJETIVO: Avaliar o efeito do programa de promoção de saúde no perfi l de 
risco cardiometabólico de nipo-brasileiros.
MÉTODOS: Um total de 466 participantes de estudo de prevalência de diabetes 
em Bauru, SP, no ano de 2000 completou um programa de intervenção de um 
ano (2005-2006) baseado em aconselhamento sobre dieta saudável e prática 
de atividade física. Alterações em pressão arterial e parâmetros metabólicos 
entre 2005 e 2006 foram comparados com alterações anuais nessas mesmas 
variáveis entre 2000 e 2005.
RESULTADOS: Durante a intervenção, foram observadas maiores reduções 
anuais médias (dp) na circunferência da cintura [-0,5(3,8) vs. 1,2(1,2) cm/ano, 
p < 0,001], pressão arterial sistólica [-4,6(17,9) vs. 1,8(4,3) mmHg/ano, p < 
0,001], glicemia 2h pós-sobrecarga de glicose [-1,2(2,1) vs. -0,2(0,6) mmol/L/
ano, p < 0,001], LDL-c [-0,3(0,9) vs. -0,1(0,2) mmol/L/ano, p < 0,001] e 
escore de Framingham [-0,25(3,03) vs. 0,11(0,66)/por ano, p = 0,02], mas não 
em triglicérides [0,2(1,6) vs. 0,1(0,42) mmol/L/ano, p < 0,001] e insulinemia 
de jejum [1,2(5,8) vs. -0,7(2,2) UI/mL/ano, p < 0,001], comparado com o 
período pré-intervenção. Ocorreram reduções signifi cativas na prevalência 
de glicemia de jejum alterada e tolerância à glicose diminuída após um ano 
de intervenção (de 58,4% para 35,4%, p < 0,001; e de 30,1% para 21,7%, p = 
0,004, respectivamente).
CONCLUSÕES: O programa de intervenção de um ano em hábitos de vida traz 
benefícios ao perfi l de risco cardiometabólico em indivíduos nipo-brasileiros 
de alto risco.
DESCRITORES: Doenças Cardiovasculares, prevenção & controle. 
Diabetes Mellitus Tipo 2, prevenção & controle. Avaliação de Efi cácia-
Efetividade de Intervenções. Educação Alimentar e Nutricional. Educação 
Física e Treinamento. Grupo com Ancestrais do Continente Asiático.
INTRODUCTION
increasing incidence rates of diabetes in several ethnic 
groups.7 High fat intake was associated with metabolic 
syndrome among Japanese-Brazilians in cross-sectional 
and longitudinal studies.3,4 The present study aimed to 
assess the effect of a 1-year community-based health 
promotion program in a population of Japanese-
Brazilians by comparing their cardiometabolic profi le 
before and after the intervention.
METHODS
Cross-sectional study carried out with subjects from 
the Study on Diabetes and Associated Diseases in a 
Population of Japanese-Brazilians conducted in the 
city of Bauru, southeastern Brazil, in 2000.5 A total of 
1,330 fi rst- (Japan-born) and second-generation (Brazil-
born) Japanese-Brazilians of both genders participated 
in the previous cross-sectional study and were invited 
to join a community-based health promotion program 
commencing in 2005.
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a World Health Organization. Food and Agricultural Organization. The scientifi c basis for diet, nutrition and the prevention of type 2 diabetes. 
Geneva; 2003.
b World Health Organization. Obesity: preventing and managing the global epidemic. Report of WHO Consultation on Obesity. Geneva; 1998. 
The study purposes and potential benefi ts of the behav-
ioral intervention were outlined in invitation letters and 
telephone contacts. The 653 subjects who agreed to 
participate in the study had lower mean (SD) body mass 
index (BMI) [24.8 (3.7) vs. 25.2 (4.2) kg/m2, p<0.05] 
and higher systolic blood pressure [134.6 (25.6) vs. 
130.0 (22.5) mmHg, p<0.05] in 2000 compared with 
non-subjects, but were otherwise similar. One year later, 
466 remained in the intervention program and were 
reevaluated in 2006. Figure 1 illustrates the study design 
including causes of non-participation. Subjects who 
were lost to follow-up in 2006 had lower 2-hour plasma 
glucose levels in 2005 than those who were reevaluated 
[7.6 (2.9) vs. 8.2 (2.9) mmol/L, p<0.02], but all other 
demographic and clinical characteristics were similar.
The results of the 466 subjects who started the inter-
vention in 2005 and remained in the program one year 
later are presented here.
The health promotion program targeted changes in 
dietary intake and levels and patterns of physical 
activity.2 It was based on World Health Organization 
(WHO) recommendationa and a previous trial conducted 
among overweight Brazilian adults.17 Over a 12-month 
period, each subject was offered one individual visit 
with a nutritionist, one group session on nutrition educa-
tion, one group session for physical activity counseling, 
and two community exercise classes including walking, 
stretching, and dancing. Group sessions included 10 
subjects and were coordinated by nutritionists and 
physical educators. The subjects’ relatives were also 
invited to join the group sessions.
Dietary recommendations consisted of changes in total 
energy intake according to each individual’s nutritional 
status; a list of food replacements was provided. The 
target proportions of macronutrients related to total 
energy intake were 50% to 60% of energy intake in 
carbohydrates; <30% in total fat; <10% in saturated 
fat; 10% to 15% in proteins; <300 mg of cholesterol 
and 15 g of vegetable fiber. Trained nutritionists 
monitored diet using 24-hour food recalls. Subjects 
were encouraged to engage in at least 30 minutes of 
physical activity per day. Compliance was estimated by 
the short version of the International Physical Activity 
Questionnaire. Physical educators and nutritionists rein-
forced the importance of adopting a healthy lifestyle and 
discussed the barriers to reaching the goals of the inter-
vention program during the group sessions. Engagement 
in other physical activities opportunities was recom-
mended. They did not receive any other counseling 
during the study period. They were instructed to maintain 
any previous medical treatment. Use of medications was 
taken into consideration in the statistical analysis.
Subjects underwent laboratory tests following standard 
multi-professional protocols in an outpatient clinic at 
baseline and after completing the 12-month interven-
tion program.
Body weight and height were measured using calibrated 
electronic scales and a fi xed rigid stadiometer, respecti-
vely, while subjects wore light clothing without shoes. 
BMI was calculated as weight (kilograms) divided 
by squared height (meters). Waist circumference was 
measured with an inextensible tape according to the 
WHO technique.b Blood pressure was taken three times 
Figure 1. Flowchart of subjects through each stage of the study. City of Bauru, southeastern Brazil, 2000, 2005 and 2006.
Year 2000
Year 2005
Year 2006
1330 eligible subjects in the Japanese-Brazilian
 Population study
653 joined the intervention program 
466 completed the one-year intervention program
677 did not join the intervention program (52%)
39% non-response or refusal
8% incorrect address
3% deceased
2% moved away
187 were lost to follow-up 
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using an automatic device (Omron model HEM-712C, 
Omron Health Care, Inc, USA) after a 5-minute rest in 
the sitting position. The mean of the second and third 
measurements was calculated.
Fasting blood samples were taken and a 75-g oral 
glucose tolerance test was performed. Samples were 
immediately centrifuged and analyzed in a local 
laboratory. Plasma glucose was measured by the 
glucose-oxidase method and lipoproteins were deter-
mined enzymatically with an automatic analyzer. The 
American Diabetes Association criteria were used 
to categorize glucose tolerance status as diabetes, 
impaired fasting glucose (IFG) and impaired glucose 
tolerance (IGT).1 All remaining samples were stored at 
-80oC prior to hormone assay. Insulin was determined 
by immunometric assay using a quantitative chemi-
luminescent kit (Euro DPC Limited - Glyn Rhonwy, 
Llanberis, Caernarfon, Gwynedd, UK), with analytical 
sensitivity of 2.0 uIU/mL; intra-assay coeffi cient of 
variability ranged from 5.3% to 6.4% and the inter-
-assay coeffi cient of variability ranged from 5.9% to 
8.0%. Insulin secretion was determined according to 
the homeostasis model assessment [HOMA- = 20 × 
fasting insulin (U/mL)/fasting glucose (mmol/L) – 
3.5].13 The cardiovascular risk score was based on equa-
tions derived from the US Framingham cohort study.6
The prevalence of IFG/IGT and diabetes in 2000, 
2005 and 2006 were compared by the chi-square test. 
For each anthropometric and metabolic characteristic 
the mean and SD were calculated in 2000, 2005 and 
2006. The annual change of each parameter from 2000 
to 2005 (calculated by subtracting the mean in 2000 
from that in 2005 and dividing by 5) and from 2005 
to 2006 were calculated and presented as mean and 
95% confi dence interval (95% CI). These differences 
from 2005 to 2006 were standardized and are shown in 
Figure 2. To compare magnitudes of changes between 
pre- and post-intervention, the differences in variable 
BP, blood pressure
IFG, impaired fasting glucose
IGT, impaired glucose tolerance
(Mean difference = mean in 2006 – mean in 2005)
HOMA-β = 20 × Fasting insulin (μU/mL) / Fasting glucose (mmol/L) – 3.5
Figure 2. Standardized differences (and related 95% confi dence interval) of anthropometric and metabolic variables between 
2005 and 2006 (panel A) and standardized differences in weight, fasting and 2-hour plasma glucose stratifi ed by glucose 
tolerance status in 2005 (panel B). City of Bauru, southeastern Brazil, 2005 and 2006. 
Weight
BMI
Waist
Systolic BP
Diastolic BP
Fasting glucose
2h-glucose
Total cholesterol
LDL-cholesterol
HDL-cholesterol
Triglyceride
Fasting insulin
Homa-ß
Framingham score
-1.5 -1 -0.5 0 0.5 1 1.5
Weight
Normal
IFG/IGT
Diabetes
Fasting glucose
Normal
IFG/IGT
Diabetes
2h-glucose
Normal
IFG/IGT
Diabetes
A B
-1.0 -0.5 0 0.5 1
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changes obtained in these two periods were calculated 
(Δ difference = change from 2005 to 2006 - annual 
change from 2000 to 2005). These differences between 
annual change in the intervention (2005-2006) and 
pre-intervention period (2000-2005) and 95% CI were 
reported alongside standardized versions of these 
differences to allow comparisons between different 
characteristics.
The differences in annual change were also estimated 
after stratifi cation by age (< 60 and ≥ 60 years old), 
generation (fi rst- and second-generation), gender and 
glucose tolerance status. Sensitivity analyses were 
conducted according to self-reported consumption of 
alcohol and use and/or change of medication (antihyper-
tensives, lipid lowering and antidiabetic agents) that 
might infl uence outcomes.
All statistical analyses were performed using SPSS 12.0.
The Research Ethics Committee approved the study 
protocol (Protocol 1710, Of.COEP/151/08) and a 
written consent was obtained from all subjects.
RESULTS
The 466 subjects had a mean age of 55.3 years in 2000; 
53.0% were women and 79.4% were second-generation 
Japanese-Brazilians.
The prevalence of IFG/IGT was stable from 2000 to 
2005 (58.8% and 58.4%, respectively) but signifi cantly 
feel during the intervention (35.4%, 2 = 49.3, p<0.001). 
The prevalence of diabetes declined from 2000 to 2005 
(from 37.3% to 30.1%, p=0.001) and further decreased 
during the intervention (from 30.1% to 21.7%, 2 = 
8.51, p=0.004).
Between 2000 and 2005 subjects showed increased 
mean weight, waist circumference, systolic and 
diastolic blood pressure and Framingham cardiovas-
cular risk score and small reductions in triglycerides, 
fasting and 2-hour plasma glucose, total, LDL and 
HDL-cholesterol levels, insulin and HOMA- levels 
(Table). Between 2005 and 2006, there were reductions 
in waist circumference, systolic and diastolic blood 
pressure, fasting and 2-hour plasma glucose, total, 
LDL and HDL-cholesterol levels, and Framingham 
cardiovascular risk score, and increases in triglyceride 
and fasting insulin levels and HOMA-. There was a 
reduction in the Framingham cardiovascular risk score 
during the one-year intervention period [0.11 (0.66) 
vs. -0.25 (3.03) per year, p=0.02], following an annual 
increase from 2000 to 2005.
The changes in variables between 2005 and 2006 
were standardized (Figure 2, panel A). Subjects with 
abnormal glucose metabolism (IFG, IGT or diabetes) 
in 2005 showed greater decreases in fasting and 2-hour 
plasma glucose following the intervention than those 
with normal glucose tolerance. Those with diabetes had 
the greatest weight loss (Figure 2, panel B).
There were signifi cantly greater improvements in the 
majority of cardiovascular risk factors post-intervention 
compared to the pre-intervention period, except for 
Table. Mean values (and standard deviation) for anthropometric and metabolic variables at the three stages of the study and 
annual differences (95% confi dence interval) in the pre- and post-intervention periods. City of Bauru, southeastern Brazil, 
2000, 2005 and 2006. (N = 466)
Variable 2000 2005 2006
Annual difference
(2000 to 2005)
Annual difference
(2005 to 2006)
Weight (kg) 61.5 (12.4) 61.6 (12.4) 61.2 (12.7) -0.01 (-0.1 to 0.05) -0.4 (-0.6 to -0.2)
Body mass index (kg/m2) 24.8 (3.7) 24.9 (4.1) 24.7 (4.1) -0.07 (-0.1 to -0.04) -0.2 (-0.3 to -0.1)
Waist circumference (cm) 84.0 (10.1) 88.5 (10.4) 88.1 (10.6) 1.2 (1.0 to 1.3) -0.5 (-0.9 to -0.2)
Systolic blood pressure (mm Hg) 134.6 (25.6) 139.3 (21.8) 134.3 (21.4) 1.8 (1.4 to 2.2) -4.6 (-6.3 to -3.0)
Diastolic blood pressure (mm Hg) 78.1 (13.9) 81.2 (12.0) 78.4 (11.6) 0.6 (0.4 to 0.8) -2.9 (-3.7 to -1.9)
Fasting plasma glucose (mmol/L) 6.9 (1.7) 6.2 (1.7) 5.8 (1.5) -0.2 (-0.2 to -0.1) -0.4 (-0.5 to -0.2)
2-hour plasma glucose (mmol/L) 9.2 (4.39) 8.3 (2.9) 7.2 (2.5) -0.2 (-0.3 to -0.2) -1.2 (-1.4 to -0.9)
Total cholesterol (mmol/L) 5.6 (1.1) 5.5 (1.1) 5.1 (1.0) -0.1 (-0.1 to -0.05) -0.4 (-0.5 to -0.1)
LDL-cholesterol (mmol/L) 3.3 (0.9) 3.3 (1.0) 3.0 (0.8) -0.1 (-0.1 to –0.05) -0.3 (-0.4 to -0.2)
HDL-cholesterol (mmol/L) 1.3 (0.3) 1.4 (0.3) 1.3 (0.3) 0.01 (-0.01 to -0.002) -0.1 (-0.2 to -0.1)
Triglycerides (mmol/L) 2.6 (2.3) 1.8 (1.4) 2.0 (1.6) 0.1 (0.1 to 0.07) 0.2 (0.04 to 0.2)
Fasting insulin (IU/mL) 9.4 (4.4) 5.9 (9.5) 7.6 (11.8) -0.7 (-0.9 to -0.5) 1.2 (0.7 to 1.8)
HOMA- 24.1 (30.4) 15.8 (30.0) 22.6 (37.9) -1.5 (-2.2 to -0.8) 6.2 (3.7 to 8.6)
Framingham coronary heart 
disease risk score
7.2 (5.4) 7.8 (4.7) 7.6 (4.3) 0.1 (0.05 to 0.2) -0.2 (-0.5 to -0.02)
Homeostasis model assessment (HOMA-) = 20 × fasting insulin (U/mL)/fasting glucose (mmol/L) -3.5
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of diabetes in a high-risk population. Our fi ndings 
support the potential for lifestyle change in diabetes 
and cardiovascular disease prevention and are broadly 
consistent with results from previous studies of more 
intensive behavioral interventions among people with 
impaired glucose tolerance.8,21 A particular strength 
of our approach was the relatively low cost, both for 
identifi cation of high-risk individuals and the interven-
tion, making it convenient in countries with limited 
resources for health.
In 2005 the study subjects were overweight and had 
a high waist circumferencec considering their overall 
mean BMI (24.7 kg/m2). Although the reductions in 
anthropometric parameters during the intervention 
were modest, statistically signifi cant and clinically 
relevant reductions were observed for blood pres-
sure, plasma glucose, glucose tolerance, and total and 
LDL-cholesterol levels among those who enrolled in 
the community program. Similar fi ndings were reported 
in diabetes prevention studies among people with IGT. 
The Da Qing Study, Finnish Diabetes Prevention Study 
(DPS), and Diabetes Prevention Program showed that 
diabetes could be prevented by sustained lifestyle 
changes associated with modest weight loss.8,14,21 In 
the Indian Diabetes Prevention Program, there was a 
26.4% reduction in the relative risk of progression to 
diabetes with almost no change in weight and waist 
circumference.15 An intensive lifestyle intervention 
among Japanese men was associated with a reduction in 
the incidence of diabetes greater than might be expected 
with a reduction in BMI,10 suggesting that while weight 
loss may be desirable, it does not fully explain the 
effects of behavioral interventions. Longer follow-up of 
the Japanese-Brazilian subjects will provide more input 
concerning the potential for sustained effects on the risk 
of diabetes and persistence of cardiometabolic benefi ts.
A limitation of this study is that no control group was 
used for comparison during the intervention. Hence 
there is a possibility that the positive fi ndings may be 
due to confounding, regression to the mean or selec-
tion bias. The difference in changes in risk factors 
over the 5-year pre-intervention period compared with 
the 1-year intervention period does not rule out these 
potential explanations but does make them less likely. 
Data from this same population in the pre-intervention 
period works as a historical control, which means that 
this study used a plausibility design.22 This type of study 
is a feasible option for large scale interventions and 
provides valid evidence of impact.22 As for regression 
to the mean, if any, it would be similar in both periods 
studied. Since confounding factors that could produce 
these benefi ts on cardiometabolic profi le were not iden-
tifi ed, the results should be attributed to intervention 
HDL-cholesterol, triglycerides, and fasting insulin 
(Figure 3).
The magnitude, direction and statistical signifi cance of 
the results were unchanged when stratifi ed by gender, 
generation and age (data not shown). They were also 
unaffected when stratifi ed by prescribed medication and 
self-reported alcohol consumption (data not shown).
DISCUSSION
This community-based study suggests that a relatively 
simple health promotion program including lifestyle 
changes counseling was associated with improved 
cardiovascular risk factors, modeled cardiovascular risk 
and glucose tolerance, and a reduction in the prevalence 
c World Health Organization. WHO 2000. Steering Committee of the Western Pacifi c Region of the WHO, the International Association for the 
Study of Obesity Task Force. The Asia-Pacifi c perspective: redefi ning obesity and its treatment. Geneva; 2000.
-1 -0.5 0 0.5 1
?Weight
?BMI
?Waist
?Systolic BP
?Diastolic BP
?Fasting glucose
?2h-glucose
?Total cholesterol
?LDL cholesterol
?HDL cholesterol
?Triglyceride
?Fasting insulin
?Homa-ß
?Framingham score
BP, blood pressure
(Difference in annual change (Δ Difference) = change from 
2005 to 2006 – change from 2000 to 2005÷5)
HOMA-β= 20 × fasting insulin (μU/mL) fasting glucose 
(mmol/L) -3.5
Figure 3. Standardized differences (and related 95% confi -
dence interval) of annual changes in variables. City of Bauru, 
southeastern Brazil, 2000-2005 and 2005-2006.
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effects. Although around half of those invited agreed 
to take part in the health promotion program, the char-
acteristics of subjects and non-subjects were broadly 
similar, also suggesting that selection bias is not likely. 
There was no allocation concealment that increases the 
likelihood of bias in the outcome assessment. However, 
it is unlikely to affect laboratory tests and all study 
measures were taken according to standard operating 
procedures, and blood pressure was measured using 
automated equipment. The sensitivity analysis also 
suggests that the fi ndings are not due to changes in 
prescribed medication over time. The  follow-up rate 
was reasonably good (71%). Those with missing data 
in 2006 were similar to those who underwent reevalu-
ation except that they showed lower 2-hour plasma 
glucose levels. If subjects who were lost to follow-up 
had more severe risk factors then the benefi ts associated 
with the community program would be overestimated. 
Although we may have underestimated the differences 
in annual change in risk factors between 2000 to 2005 
and 2005 to 2006 as the fi rst period of observation was 
about more than fi ve times as long as the second one.
The effects of the health promotion program were not 
modifi ed by age, gender or generation; however, those 
with abnormal glucose metabolism in 2005 had greater 
decreases in plasma glucose during the intervention 
than those with normal glucose tolerance. The unex-
pected decrease in HDL-cholesterol (albeit remaining 
within the normal range) and increase in triglyceride 
levels persisted after sensitivity analyses. The changes 
in physical activity may not have been strong enough to 
induce an increase in HDL-cholesterol levels. Given the 
harmful effect of fat intake on cardiometabolic profi le 
in this population, as previously shown by our group,3,4 
the study dietary counseling strongly advocated a reduc-
tion in food consumption rich in fat. This could have 
resulted in a relative increase in carbohydrate intake 
which might have contributed to increased triglyceride 
levels.18 Analyses of self-reported physical activity and 
diet data may help better understand these fi ndings 
and possible mechanisms by which the intervention 
program appears to have produced benefi cial effects. 
Fasting insulin levels increased post-intervention. As 
the HOMA-β was also higher after the intervention, it 
is possible that lifestyle changes were associated with 
improved beta cell function which was also refl ected in 
the benefi cial changes in metabolic parameters.
We do not know whether other discrete high–risk 
population subgroups would have the same uptake 
of, or response to, a health promotion program as 
seen among Japanese descendants. The benefi ts of the 
present program cannot be extrapolated to the entire 
Brazilian population or Asian immigrants living in other 
countries. We also cannot assure these changes will be 
sustained. Albeit more pronounced than in this study, 
evidence from the Finnish DPS shows that the benefi ts 
of behavioral interventions can persist following cessa-
tion of the intervention.12 It contrasts with the effect of 
risk reduction associated with the use of antidiabetic 
drugs which ceases when the medication is discon-
tinued.9 It is also unclear whether improvements in 
proximal risk factors will translate into reductions in 
unfavorable health outcomes, although recent data from 
the long-term follow-up of the Da Qing Study looks 
promising.11 Follow-up of Japanese-Brazilian subjects 
may clarify whether changes in cardiometabolic risk 
factors will translate into the prevention of cardiovas-
cular events. Furthermore, lifestyle changes which 
probably accounted for the observed improvements in 
risk factors might also be associated with reduced risk 
of other adverse health outcomes such as osteoporosis 
and some cancers.
A simple community-based behavioral counseling 
program over one year improved the cardiometabolic 
profi le in a high-risk population of Japanese-Brazilians. 
Obesity, diabetes, and their complications pose major 
public health challenges demanding responses at the 
population and individual level. Our fi ndings should 
encourage health care providers to promote a healthy 
diet and a physically active lifestyle among high-risk 
individuals and population subgroups.
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